NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Ann
Saturday, April 5, 2025 03:55:12 AM
Post# of 387
Post# of 387
(Total Views: 255)
Posted On: 04/19/2022 3:42:05 PM
NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Panels and Featured Speakers for 4/20 Event
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced speakers for the Sequire Cannabis & Psychedelic Conference taking place on April 20, 2022. The event will showcase over 30 cannabis and psychedelic companies hosting 25 minute presentations, one-on-one investor meetings, and keynotes highlighting notable names in these spaces. The panels and featured speakers include a discussion on “Exploring the Value and Application of Botanical and Synthetic Formulations in Psychedelic Medicine,” in which Dr. Matt Johnson, Joel Stanley and David Drapkin will discuss clinical research on psychedelic compounds. “Building an Industry Worthy of the Plant,” will feature Steve DeAngelo and Andrew DeAngelo as they share insider knowledge about the current cannabis landscape, latest developments and what to expect in the near future with expanding cannabis legalization. In addition, during his speech, “Debt Capital for Everyone,” James Dworkin, managing director of Seaport Global Securities, will share insight on the state of the cannabis debt, equity, and M&A markets, and how everyone can access them.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced speakers for the Sequire Cannabis & Psychedelic Conference taking place on April 20, 2022. The event will showcase over 30 cannabis and psychedelic companies hosting 25 minute presentations, one-on-one investor meetings, and keynotes highlighting notable names in these spaces. The panels and featured speakers include a discussion on “Exploring the Value and Application of Botanical and Synthetic Formulations in Psychedelic Medicine,” in which Dr. Matt Johnson, Joel Stanley and David Drapkin will discuss clinical research on psychedelic compounds. “Building an Industry Worthy of the Plant,” will feature Steve DeAngelo and Andrew DeAngelo as they share insider knowledge about the current cannabis landscape, latest developments and what to expect in the near future with expanding cannabis legalization. In addition, during his speech, “Debt Capital for Everyone,” James Dworkin, managing director of Seaport Global Securities, will share insight on the state of the cannabis debt, equity, and M&A markets, and how everyone can access them.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)SRAX Inc. (SRAX) Stock Research Links
Scroll down for more posts ▼